|
ZNF174 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.762900E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.70129999999791E-05 |
| Normal-vs-Stage2 |
4.450200E-01 |
| Normal-vs-Stage3 |
6.548200E-01 |
| Normal-vs-Stage4 |
2.422800E-01 |
| Stage1-vs-Stage2 |
5.704000E-02 |
| Stage1-vs-Stage3 |
1.436420E-03 |
| Stage1-vs-Stage4 |
1.972210E-02 |
| Stage2-vs-Stage3 |
6.687200E-01 |
| Stage2-vs-Stage4 |
8.755800E-01 |
| Stage3-vs-Stage4 |
4.809000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.417570E-02 |
| Normal-vs-AfricanAmerican |
4.629700E-02 |
| Normal-vs-Asian |
1.661400E-01 |
| Caucasian-vs-AfricanAmerican |
4.280400E-01 |
| Caucasian-vs-Asian |
2.591200E-01 |
| AfricanAmerican-vs-Asian |
3.428200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.188160E-01 |
| Normal-vs-Female |
7.89860000000031E-05 |
| Male-vs-Female |
1.319370E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.370800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.183700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.066200E-02 |
| Normal-vs-Age(81-100Yrs) |
8.249400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.872400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.996000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.708400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.999000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.015400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.319000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.999700E-03 |
| Normal-vs-Grade 2 |
7.71470000000551E-05 |
| Normal-vs-Grade 3 |
1.483230E-01 |
| Normal-vs-Grade 4 |
6.189000E-01 |
| Grade 1-vs-Grade 2 |
2.085900E-02 |
| Grade 1-vs-Grade 3 |
1.619620E-02 |
| Grade 1-vs-Grade 4 |
4.961000E-03 |
| Grade 2-vs-Grade 3 |
2.919000E-03 |
| Grade 2-vs-Grade 4 |
2.589500E-04 |
| Grade 3-vs-Grade 4 |
8.005800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.66130000037279E-07 |
| Normal-vs-ccB subtype |
8.592800E-01 |
| ccA subtype-vs-ccB subtype |
6.93370000304228E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.592300E-02 |
| Normal-vs-N1 |
5.788000E-01 |
| N0-vs-N1 |
2.249200E-01 |
|
|
